DEA Puts Marijuana Rescheduling on Hold — Government Has Until Tomorrow (October 13) to Respond

The long-running federal effort to move marijuana from Schedule I to Schedule III of the Controlled Substances Act has hit another delay — this time over a government watchdog report questioning how the decision is being made.


DEA headquarters Washington DC

On September 29, DEA Chief Administrative Law Judge Derek C. Julius temporarily stayed the rescheduling proceeding while he considers whether to admit a September 23 report from the Government Accountability Office into the official record, and to allow extra briefing on its findings.


The GAO report found gaps in the written policies and procedures the DEA and the FDA use to evaluate and schedule controlled substances — including two different standards for judging whether marijuana has an accepted medical use. The judge has given the federal government until tomorrow, October 13, 2026, to respond.


Judge's gavel with cannabis leaves
Importantly, the pause does not undo the April 2026 final rule that already moved FDA-approved
marijuana drug products and state-licensed medical marijuana to Schedule III. Only the broader question — whether all marijuana should be rescheduled — is on hold.


The stay was requested by three parties opposed to broader rescheduling, including the National Drug & Alcohol Screening Association. It adds another chapter to a process that has stretched across two administrations, despite President Trump's December 2025 executive order directing officials to complete rescheduling "in the most expeditious manner."


Calendar showing October 13 deadline circled

All eyes are now on tomorrow. Watch this space for the next development.

Comments

Popular posts from this blog

Sir Patrick Stewart Dies at 86: Star Trek's Captain Picard and X-Men's Professor X Remembered

"Healey's £20 Billion Bet: Chancellor Arms Britain's State Banks to Back AI, Defence and Green Energy"